MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01120nam a22003017i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
6114 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
PILC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240720152535.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
160505b2015 xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781118892541 |
| 040 ## - CATALOGING SOURCE |
|---|
| Description conventions |
rda |
| Transcribing agency |
FEU-NRMF MEDICAL LIBRARY |
| Language of cataloging |
eng |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RS 431.L435 2015 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Lednicer, Daniel, |
| Dates associated with a name |
1929- |
| Relator term |
author |
| 110 ## - MAIN ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Ohio Library and Information Network |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Antineoplastic Drugs :organic synthesis / |
| Statement of responsibility, etc. |
Daniel Lednicer. |
| 264 ## - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Chichester, West Sussex : |
| Name of producer, publisher, distributor, manufacturer |
John Wiley and Sons, Inc., |
| Date of production, publication, distribution, manufacture, or copyright notice |
2015. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
213 pages |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text txt|2rdacontent. |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer c|2rdamedia. |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource cr|2rdacarrier. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
"Antineoplastic Drugs: Organic Syntheses is written to appeal to organic and medicinal chemists in industry and academia. It is beneficial to those composing grant proposals for NCI and related organizations"-- Provided by publisher. |
| 521 ## - TARGET AUDIENCE NOTE |
|---|
| Target audience note |
School of Pharmacy |
| 521 ## - TARGET AUDIENCE NOTE |
|---|
| Target audience note |
School of Medicine |
| 521 ## - TARGET AUDIENCE NOTE |
|---|
| Target audience note |
Department of Pharmacology |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Antineoplastic agents |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Synthesis |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Books Overnight |
